Global Pharmaceutical Intermediates Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Pharmaceutical Intermediates Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Type
  • 1.4.2 GMP
  • 1.4.3 Non-GMP
• 1.3 Market by Application
  • 1.3.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Application
  • 1.3.2 Antibiotics
  • 1.3.3 Antipyretic Analgesics
  • 1.3.4 Vitamins
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Pharmaceutical Intermediates Sales Estimates and Forecasts 2016-2027
• 2.2 Global Pharmaceutical Intermediates Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Pharmaceutical Intermediates Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Pharmaceutical Intermediates Regions by Sales
  • 2.4.1 Global Top Pharmaceutical Intermediates Regions by Sales (2016-2021)
  • 2.4.2 Global Top Pharmaceutical Intermediates Regions by Sales (2022-2027)
• 2.5 Global Top Pharmaceutical Intermediates Regions by Revenue
  • 2.5.1 Global Top Pharmaceutical Intermediates Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Pharmaceutical Intermediates Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Pharmaceutical Intermediates Sales by Manufacturers
  • 3.1.1 Global Top Pharmaceutical Intermediates Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Pharmaceutical Intermediates Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Pharmaceutical Intermediates Sales in 2020
• 3.2 Global Pharmaceutical Intermediates Revenue by Manufacturers
  • 3.2.1 Global Top Pharmaceutical Intermediates Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Pharmaceutical Intermediates Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Pharmaceutical Intermediates Revenue in 2020
• 3.3 Global Pharmaceutical Intermediates Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Pharmaceutical Intermediates Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Pharmaceutical Intermediates Sales by Type
  • 4.1.1 Global Pharmaceutical Intermediates Historical Sales by Type (2016-2021)
  • 4.1.2 Global Pharmaceutical Intermediates Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Pharmaceutical Intermediates Sales Market Share by Type (2016-2027)
• 4.2 Global Pharmaceutical Intermediates Revenue by Type
  • 4.2.1 Global Pharmaceutical Intermediates Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Pharmaceutical Intermediates Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Pharmaceutical Intermediates Revenue Market Share by Type (2016-2027)
• 4.3 Global Pharmaceutical Intermediates Price by Type
  • 4.3.1 Global Pharmaceutical Intermediates Price by Type (2016-2021)
  • 4.3.2 Global Pharmaceutical Intermediates Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Pharmaceutical Intermediates Sales by Application
  • 5.1.1 Global Pharmaceutical Intermediates Historical Sales by Application (2016-2021)
  • 5.1.2 Global Pharmaceutical Intermediates Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Pharmaceutical Intermediates Sales Market Share by Application (2016-2027)
• 5.2 Global Pharmaceutical Intermediates Revenue by Application
  • 5.2.1 Global Pharmaceutical Intermediates Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Pharmaceutical Intermediates Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Pharmaceutical Intermediates Revenue Market Share by Application (2016-2027)
• 5.3 Global Pharmaceutical Intermediates Price by Application
  • 5.3.1 Global Pharmaceutical Intermediates Price by Application (2016-2021)
  • 5.3.2 Global Pharmaceutical Intermediates Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Pharmaceutical Intermediates Market Size by Type
  • 6.1.1 North America Pharmaceutical Intermediates Sales by Type (2016-2027)
  • 6.1.2 North America Pharmaceutical Intermediates Revenue by Type (2016-2027)
• 6.2 North America Pharmaceutical Intermediates Market Size by Application
  • 6.2.1 North America Pharmaceutical Intermediates Sales by Application (2016-2027)
  • 6.2.2 North America Pharmaceutical Intermediates Revenue by Application (2016-2027)
• 6.3 North America Pharmaceutical Intermediates Market Size by Country
  • 6.3.1 North America Pharmaceutical Intermediates Sales by Country (2016-2027)
  • 6.3.2 North America Pharmaceutical Intermediates Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Pharmaceutical Intermediates Market Size by Type
  • 7.1.1 Europe Pharmaceutical Intermediates Sales by Type (2017-2027)
  • 7.1.2 Europe Pharmaceutical Intermediates Revenue by Type (2017-2027)
• 7.2 Europe Pharmaceutical Intermediates Market Size by Application
  • 7.2.1 Europe Pharmaceutical Intermediates Sales by Application (2017-2027)
  • 7.2.2 Europe Pharmaceutical Intermediates Revenue by Application (2017-2027)
• 7.3 Europe Pharmaceutical Intermediates Market Size by Country
  • 7.3.1 Europe Pharmaceutical Intermediates Sales by Country (2017-2027)
  • 7.3.2 Europe Pharmaceutical Intermediates Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Pharmaceutical Intermediates Market Size by Type
  • 8.1.1 Asia Pacific Pharmaceutical Intermediates Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Pharmaceutical Intermediates Revenue by Type (2018-2027)
• 8.2 Asia Pacific Pharmaceutical Intermediates Market Size by Application
  • 8.2.1 Asia Pacific Pharmaceutical Intermediates Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Pharmaceutical Intermediates Revenue by Application (2018-2027)
• 8.3 Asia Pacific Pharmaceutical Intermediates Market Size by Region
  • 8.3.1 Asia Pacific Pharmaceutical Intermediates Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Pharmaceutical Intermediates Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Pharmaceutical Intermediates Market Size by Type
  • 9.1.1 Latin America Pharmaceutical Intermediates Sales by Type (2019-2027)
  • 9.1.2 Latin America Pharmaceutical Intermediates Revenue by Type (2019-2027)
• 9.2 Latin America Pharmaceutical Intermediates Market Size by Application
  • 9.2.1 Latin America Pharmaceutical Intermediates Sales by Application (2019-2027)
  • 9.2.2 Latin America Pharmaceutical Intermediates Revenue by Application (2019-2027)
• 9.3 Latin America Pharmaceutical Intermediates Market Size by Country
  • 9.3.1 Latin America Pharmaceutical Intermediates Sales by Country (2019-2027)
  • 9.3.2 Latin America Pharmaceutical Intermediates Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Pharmaceutical Intermediates Market Size by Type
  • 6.1.1 Middle East and Africa Pharmaceutical Intermediates Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Pharmaceutical Intermediates Market Size by Application
  • 6.2.1 Middle East and Africa Pharmaceutical Intermediates Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Pharmaceutical Intermediates Market Size by Country
  • 6.3.1 Middle East and Africa Pharmaceutical Intermediates Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Lonza
  • 11.1.1 Lonza Corporation Information
  • 11.1.2 Lonza Overview
  • 11.1.3 Lonza Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Lonza Pharmaceutical Intermediates Product Description
  • 11.1.5 Lonza Related Developments
• 11.2 Catalent
  • 11.2.1 Catalent Corporation Information
  • 11.2.2 Catalent Overview
  • 11.2.3 Catalent Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Catalent Pharmaceutical Intermediates Product Description
  • 11.2.5 Catalent Related Developments
• 11.3 Patheon
  • 11.3.1 Patheon Corporation Information
  • 11.3.2 Patheon Overview
  • 11.3.3 Patheon Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Patheon Pharmaceutical Intermediates Product Description
  • 11.3.5 Patheon Related Developments
• 11.4 Jubilant
  • 11.4.1 Jubilant Corporation Information
  • 11.4.2 Jubilant Overview
  • 11.4.3 Jubilant Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Jubilant Pharmaceutical Intermediates Product Description
  • 11.4.5 Jubilant Related Developments
• 11.5 Granules
  • 11.5.1 Granules Corporation Information
  • 11.5.2 Granules Overview
  • 11.5.3 Granules Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Granules Pharmaceutical Intermediates Product Description
  • 11.5.5 Granules Related Developments
• 11.6 Ganesh
  • 11.6.1 Ganesh Corporation Information
  • 11.6.2 Ganesh Overview
  • 11.6.3 Ganesh Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Ganesh Pharmaceutical Intermediates Product Description
  • 11.6.5 Ganesh Related Developments
• 11.7 Chemcon
  • 11.7.1 Chemcon Corporation Information
  • 11.7.2 Chemcon Overview
  • 11.7.3 Chemcon Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Chemcon Pharmaceutical Intermediates Product Description
  • 11.7.5 Chemcon Related Developments
• 11.8 BASF
  • 11.8.1 BASF Corporation Information
  • 11.8.2 BASF Overview
  • 11.8.3 BASF Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 BASF Pharmaceutical Intermediates Product Description
  • 11.8.5 BASF Related Developments
• 11.9 Porton
  • 11.9.1 Porton Corporation Information
  • 11.9.2 Porton Overview
  • 11.9.3 Porton Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Porton Pharmaceutical Intermediates Product Description
  • 11.9.5 Porton Related Developments
• 11.10 Lianhetech
  • 11.10.1 Lianhetech Corporation Information
  • 11.10.2 Lianhetech Overview
  • 11.10.3 Lianhetech Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Lianhetech Pharmaceutical Intermediates Product Description
  • 11.10.5 Lianhetech Related Developments
• 11.1 Lonza
  • 11.1.1 Lonza Corporation Information
  • 11.1.2 Lonza Overview
  • 11.1.3 Lonza Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Lonza Pharmaceutical Intermediates Product Description
  • 11.1.5 Lonza Related Developments
• 11.12 Tianma
  • 11.12.1 Tianma Corporation Information
  • 11.12.2 Tianma Overview
  • 11.12.3 Tianma Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 Tianma Product Description
  • 11.12.5 Tianma Related Developments
• 11.13 Jiujiujiu
  • 11.13.1 Jiujiujiu Corporation Information
  • 11.13.2 Jiujiujiu Overview
  • 11.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 Jiujiujiu Product Description
  • 11.13.5 Jiujiujiu Related Developments
• 11.14 Alpha
  • 11.14.1 Alpha Corporation Information
  • 11.14.2 Alpha Overview
  • 11.14.3 Alpha Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.14.4 Alpha Product Description
  • 11.14.5 Alpha Related Developments
• 11.15 Jiuzhou
  • 11.15.1 Jiuzhou Corporation Information
  • 11.15.2 Jiuzhou Overview
  • 11.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.15.4 Jiuzhou Product Description
  • 11.15.5 Jiuzhou Related Developments
• 11.16 Yongtai
  • 11.16.1 Yongtai Corporation Information
  • 11.16.2 Yongtai Overview
  • 11.16.3 Yongtai Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.16.4 Yongtai Product Description
  • 11.16.5 Yongtai Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Pharmaceutical Intermediates Value Chain Analysis
• 12.2 Pharmaceutical Intermediates Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Pharmaceutical Intermediates Production Mode & Process
• 12.4 Pharmaceutical Intermediates Sales and Marketing
  • 12.4.1 Pharmaceutical Intermediates Sales Channels
  • 12.4.2 Pharmaceutical Intermediates Distributors
• 12.5 Pharmaceutical Intermediates Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Pharmaceutical Intermediates Industry Trends
• 13.2 Pharmaceutical Intermediates Market Drivers
• 13.3 Pharmaceutical Intermediates Market Challenges
• 13.4 Pharmaceutical Intermediates Market Restraints

14 Key Findings in The Global Pharmaceutical Intermediates Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details